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1.  ACRONYMS AND ABBREVIATIONS 
 
 
HIV – Human Immunodeficiency Virus 
 
STI   –          Sexually Transmitted infection 
 
NACO  –         National Aids Control Organization 
 
AP  –          Andhra Pradesh 
  
HLA  –          Human Leukocyte Antigen 
 
RNA   –          Ribonucleic acid 
 
MSM   –          Males who have Sex with males 
 
CCR5  –          Chemokine (C-C motif) receptor 5 
 
HSV 2  –          Herpes Simplex Virus 2 
 
CD4  –          Cluster of Differentiation 4 (glycoprotein) 
 
NRTI  –          Nucleoside Reverse Transcriptase Inhibitors 
 
NNRTI  –          Non-nucleoside Reverse Transcriptase Inhibitors 
 
NtRTI   –          Nucleotide Reverse Transcriptase Inhibitors 
 
Th1  –          T Helper 1 
 
CTL   –          Cytotoxic T Lymphocyte 
 
MHC  –          Major Histocompatibility Complex 
 
YRG CARE  -  Y.R. Gaitonde Centre for AIDS Research and Education 
 
ART  –          Anti-Retroviral Therapy 
 
 
 
 
2. ABSTRACT 
 
Sexual transmission is the major route of HIV transmission among partners. Despite 
living in partnership about 44% of couples in South India are serodiscordant for HIV 
infection. This case control study was therefore done to identify factors influencing HIV 
transmission among couples in whom both or either partner was HIV infected. Newly 
detected HIV infected patients and their partners who were either seroconcordant or 
discordant were included from South India. Details of social and sexual behavioural 
practices which could possibly affect HIV transmission were collected by a standard 
interview to each individual partner. Each partner was examined and staged clinically 
according to the WHO classification.CD4 counts were enumerated and partners were 
counseled on safe sexual practices. The factor which had a statistically significant 
increased risk for HIV transmission was a CD4 lymphocyte count < 350 cells/mm3 
.Alcohol consumption, smoking, increased frequency of sexual intercourse, genital ulcer 
disease and urethro-vaginal discharge are associated with an increased risk for 
transmitting HIV to uninfected partner. Regular condom use, abstinence and male 
circumcision protect seronegative partners from HIV acquisition. Lesser frequency of 
sexual intercourse prior to serodetection, increased condom use after serodetection and 
CD4 lymphocyte counts > 350 cells/mm protect against transmission even after l0 years 
of living as partners. Therefore counseling of partners who are discordant for HIV 
infection should be intensified on safe sex practices. ART should be initiated early in 
such patients to prevent HIV transmission  
 
 
 
 
 
 
 
 
3. AIM 
 
To identify the risk factors associated with transmission of human immunodeficiency 
virus (HIV) to uninfected married partner. 
 
 
 
 
 
 
 
 
 
 
 
4. OBJECTIVES 
 
1. To identify social risk factors involved in HIV transmission to uninfected partner. 
2. To assess sexual behaviour pattern in uninfected partner. 
3. To correlate the clinical stage of HIV disease associated with transmission.  
4. To correlate the immunological stage of HIV disease with transmission 
 
 
 
 
          
               
 
 
 
 
5 . 0  R E V I E W  O F  L I T E R A T U R E  
 
 5.1 INTRODUCTION 
 
HIV prevalence in India is 1.7% among adults 1 with the highest prevalence in Andhra 
Pradesh (A.P) – 3.3% 2.Sexual route is responsible for 85% of the route for HIV 
transmission.3 .  
 
Till recently the National AIDS Control Organization (NACO) has calculated the annual 
burden of HIV by sentinel surveillance in the public sector such as antenatal  and STI 
clinics at medical colleges or district head-quarter hospitals and high risk groups like 
female sex workers, intravenous drug users and males who have sex with males (MSM). 
This data cannot be directly extrapolated to the general population as the prevalence of 
HIV. Therefore population based prevalence estimates are required. A large population 
based prevalence study done in Guntur district of AP compared population based 
prevalence data with data from sentinel surveillance .This study found that sentinel 
surveillance data over-estimated the HIV prevalence by 2.5 times.1 
 
HIV concordance (i.e. both partners being positive) in South Indian population is 
estimated to be 56% and the remaining 44% are discordant 4. Thus there exists an equally 
large number of HIV discordant couples. HIV transmission per coital act is 0.0001- 
0.0020. 5-8. Several factors have been implicated that facilitate virus transmission and 
several that protect persons from HIV acquisition. (Table 1 and 2). 
 
This study was therefore done to study behavioural and  social factors implicated in HIV 
transmission and also to see whether clinical and immunological stage of the disease had 
any influence on HIV positive serodiscordance or concordance. This study differs from 
the one done by YRG CARE, Chennai 4 in that, this covers a rural and semi-urban 
population of South India compared to the urban population enrolled in the former study. 
There may therefore be differences between these 2 groups of the population with regard 
to behavioural practices, lifestyle, education etc. which may affect HIV transmission. 
Also, this study was done to study HIV transmission only in married couples who reside 
together.  
 
 
 
5.2 TABLE 1 SHOWS FACTORS FOUND TO FACILITATE HIV  
             TRANSMISSION   
  
1. High HIV viral load and advanced stage of disease.9-12 
2. High risk behaviour ( exposure to commercial sex workers or multiple 
heterosexual or homosexual partners ).4,12,14 
3. Presence of other sexually transmitted diseases.15-24 
4. Characteristics of the virus like syncytia inducing capability.25 
5. Certain HLA subtypes.26 
 
 
 
 
 
 
 
 
5.3 TABLE 2 SHOWS FACTORS FOUND TO PROTECT AGAINST  
       TRANSMISSION 
 
1. Barrier contraception and abstinence.4,6,12,14,27 
2. Male circumcision.28-33 
3. Use of anti-retroviral therapy.34-46 
4. Homozygosity for CCR5 mutation in the chemokine receptor gene.47 
5. Cell mediated immune responses and cytotoxic T lymphocyte activity.48-55 
6. Antibody directed against gene products of the major histocompatability 
complex.56-58 
 
 
5 . 2  F A C T O R S  F A C I L I T A T I N G  H I V  T R A N S M I S S I O N : -  
 
 
5.2.1 HIV VIRAL LOAD AND ADVANCED STAGE OF DISEASE 
 
Several studies have demonstrated that transmission of HIV among partners is correlated 
with higher HIV viral load. In a large cohort study in Uganda ,HIV transmission among 
initially discordant couples occurred in those who had higher HIV-1 RNA levels (90,254 
copies per ml vs. 38,029 copies per ml).For each log increment in viral load the rate ratio 
for the risk of transmission was 2.45 9. 
        A similar but smaller cohort in Italy showed higher HIV-1 RNA copies among index 
cases who transmitted infection when compared to index cases who did not (46,200 – 
3,42,000 vs. 16,500 – 41,870 copies/ml.) 10 . High HIV viral loads are found in both the 
early acute phase and more advanced stages and transmission occurs at both these times. 
  
[The numbers in parentheses suggest the probabilityof HIV transmission per episode of penile–vaginal 
intercourse].11 
It is easy to understand that sexual behavioural practices decline in patients with 
advanced stage of disease due to their morbid state. However, the heterosexual HIV 
transmission study, New Jersey showed that people with a more advanced HIV stage did 
not have any significant difference in sexual behavioural practices from those with less 
advanced HIV disease 12.This was in terms of practice of anal sex, condom use or 
abstinence. 
 
5.2.2 HIGH RISK BEHAVIOUR 
 
Results of the heterosexual HIV transmission study showed that before knowledge of 
HIV seropositivity (a) men among discordant couples had fewer life-time sexual  
 partners than in concordant couples. (b) frequency of vaginal sex before knowledge of the 
male partner’s seropositivity was not significantly different between concordant and 
discordant couples. (c) Over 80% of the couples never used condoms during vaginal sex 
and condom use was similar in both discordant and concordant couples. (d) frequency of 
anal sex was significantly higher among concordant than discordant couples. (e) there 
were no differences in the frequency of vaginal intercourse during menstruation, fellatio 
or cunnilingus among discordant and concordant couples. 
           After HIV status was known , it was found that concordant and discordant 
couples differed in the proportions that abstained from sex (13% concordant vs. 17%  
discordant), using condoms at least some of the time ( 60% vs. 72%) and in never using 
condoms (27% vs. 10%)  12. 
           In another cross-sectional study 4 done in Chennai, the rates of abstinence were 
significantly higher compared to the American study (39% concordant and 49% 
discordant). 
          A 7- year cohort study done in four African cities showed duration of marriage to 
be another risk factor that co-related with HIV positive concordant serostatus 13. 
          A cross-sectional study of HIV concordant and discordant partners in Uganda 
showed that living together is another factor associated with HIV positive concordance14. 
 
 
 
 
5.2.3 SEXUALLY TRANSMITTED DISEASES 
 
Herpes Simplex virus 2 (HSV-2) is the primary cause for genital herpes. Infection with 
HSV-2 has been shown to increase susceptibility to HIV by disturbing the mucosal 
barrier 15 and by the inflammatory changes which increase recruitment of HIV target cells 
to the ulcer 15, 16. But genital ulcer disease may also be a symptom of acute 
seroconversion illness17. It has been reported by 15% of individuals during the 
seroconversion illness. It is also found to be more common in patients prevalent with 
HIV 18, 19. 
       Therefore, there are questions as to whether genital ulcer disease actually precedes 
HIV seroconversion or occurs during or after seroconversion. This was 
addressed in a nested case control study in Rakai,Uganda 20 where participants in the 
longitudinal cohort who were initially HIV seronegative where questioned about 
genital ulcer disease ,prior to HIV sero-conversion, at sero-conversion and 10 months 
post-seroconversion. HSV-2 serology testing was done. They were compared with 
participants who did not HIV seroconvert. This study showed that prevalence of 
symptomatic genital ulcer disease is increased both during the period of HIV 
seroconversion and after HIV acquisition and this increase is mainly observed among 
HSV-2 seropositive individuals 20. Reactivated ulcerative herpes could account for the 
increase in genital ulcer disease after HIV acquisition. This has been shown among 
pregnant women who acquire HIV-121. 
       Also HSV-2 induced asymptomatic micro-ulceration could contribute to increased 
risk of HIV infection. Once HIV is acquired, the immunosuppression  
 caused by HIV could exacerbate the ulcer and cause symptomatic genital ulcer disease. 
       HSV-2 also upregulates HIV replication, causing higher viral loads for a short-term. 
This leads to increased rates of transmission and faster progression to  
AIDS5, 22, 23,24 . 
       A cross-sectional study done in four cities in sub-Saharan Africa to study factors 
influencing HIV concordance among married couples showed in multivariate analysis, 
that HSV-2  seropositivity was the only factor influencing concordance 13. 
 
5.2.4 PRESENCE OF CERTAIN HLA SUBTYPES 
In an observational study among hemophiliacs in Italy it was found that HLA A2 was 
significantly associated with HIV seropositivity whereas HLA types BW52 and DR4 
were negatively associated with seroconversion 26. 
 
5.3 PROTECTIVE FACTORS 
5.3.1 BARRIER CONTRACEPTION AND ABSTINENCE 
Although barrier contraception has been proven to decrease HIV transmission 27,6a study 
among discordant couples in south India showed no statistically significant difference in 
the concordance rates with condom use 4. This study also showed that the reported 
frequency of intercourse did not influence concordance and discordance. But abstinence 
was quite common after the diagnosis of HIV infection (39% among concordant and 49% 
among discordant couples). 
               A Ugandan study however showed an increased risk of 2.4 for women who had 
not used condoms during their last exposure14. 
               The Heterosexual HIV transmission study showed a 70% protective effect for 
abstinence and condom use on HIV transmission. 12. 
 
5.3.2 CIRCUMCISION 
Most cases of primary HIV infection involve HIV binding to the CD4 and CCR5 
receptors found on antigen presenting cells-macrophages,Langerhan’s cells and  
dendritic cells in the genital and rectal mucosa. About 70 % of men infected with HIV 
acquire the virus through vaginal sex and a smaller number from insertive anal 
intercourse 28. 
                  The uncircumcised penis consists of the penile shaft, glans, urethral meatus, 
inner and outer surface of the fore-skin and the frenulum (the thin band connecting the 
inner foreskin to the ventral aspect of the glans). A keratinized stratified squamous 
epithelium covers the penile shaft and outer surface of the fore-skin. This provides a 
protective barrier against HIV infection. In contrast, the inner mucosal surface of the 
fore-skin is not keratinized 29 and is rich in Langerhan’s cells30, making it susceptible to 
the virus. During heterosexual intercourse, the fore-skin is pulled back down the shaft of 
the penis and the whole inner surface of the fore-skin is exposed to vaginal secretions, 
providing a large area where HIV transmission could take place. The epithelium of the 
glans in circumcised and uncircumcised men is equally keratinized. In circumcised 
males, only the distal penile urethra is lined with mucosal epithelium. However this is 
unlikely to be a common site of infection because it contains comparatively few 
Langerhan’s cells 30. 
                 Ulcerative or inflammatory lesions of the penile urethra, fore-skin, frenulum or 
glans that are caused by other sexually transmitted infections may provide additional 
potential routes for HIV transmission. In uncircumcised males , the highly vascular 
frenulum is particularly susceptible to trauma during intercourse and lesions produced by 
other STI’s commonly occur there. Thus male circumcision further reduces the risk of 
infection by reducing the synergy that normally exists between HIV and other STI’s 16. 
                Several observational studies and a large cohort study in Uganda had earlier 
shown significant protective effect of male circumcision on HIV transmission 31,32. 
However randomized controlled trials were lacking. Therefore this could not be 
recommended as a preventive measure for the general population. Recently 2 randomized 
controlled trials in Kenya and Uganda showed 53% and 48% reduction of risk of HIV 
acquisition among HIV negative men who were at high risk and were circumcised 33. 
 
5.3.3 USE OF ANTIRETROVIRAL THERAPY 
ART has been shown to reduce HIV RNA concentrations in blood, seminal plasma 34, 
female genital tract secretions 35 and rectal secretions 36. Therefore ART is expected to 
reduce infectiousness when used for treatment. Penetration of antiviral agents into 
genital tract secretions is dictated by the degree of protein binding. Highly protein bound 
drugs are found in lesser concentrations in the genital tract. 
Fusion inhibitors < Protease inhibitors < NNRTI’s < NRTI’s or NtRTI’s. 
Retrospective and prospective evaluation of HIV transmission in sero-discordant couples 
has shown decreased risk of transmission for those on ART. Risk of transmission 
decreased by 50% in a study by Musico et al 37 and by 86% in a study by Castilla and 
colleagues 38. Similar findings were also reported by others 39, 40. 
            On analysis of population trends, Porco et al found a 60% reduction in anticipated 
cases of HIV among a homosexual cohort in SanFrancisco 41.Similar  
results were found by Fang et al in Taiwan 42 – 53% reduction in expected cases and 
Montaner et al in British Columbia 43 – 50% reduction in expected cases by ART. 
             However other ecologic studies have shown disappointing results 44, 45. The 
patients in these studies who received anti-retroviral therapy had an increased incidence 
of other STI’s. This indicated ongoing risk taking behaviour in these patients. This could 
suggest that the availability of effective HIV treatment increased high risk sexual 
behaviour in this populations studied and may be attributed to the possible feeling of well 
– being experienced by patients on anti-retroviral therapy. 
              The degree to which ART will reduce infectivity at the individual level is also 
not known 46. 
  
5.3.4 HOMOZYGOSITY FOR CCR5 MUTATION IN THE CHEMOKINE 
RECEPTOR GENE 
 
The CCR5 gene serves as a secondary receptor on CD4 T lymphocytes for certain strains 
of HIV-1.The CCR5 gene was mapped to human chromosome 3p21.A 32 base pair 
deletion allele (CCR5∆32) was identified. This is present at a frequency of 0.10 in the 
Caucasian population of the United States. 
On examining 1955 patients enrolled in 6 cohort studies it was found that among 612 
exposed but HIV negative individuals, 17 were homozygous for CCR5∆32.This deletion 
was not found at all among the 1343 who were HIV infected. 
This indicates that homozygosity for CCR5∆32 might confer resistance to HIV 
acquisition 47. 
 
5.3.5 CELL MEDIATED IMMUNE RESPONSES – CYTOTOXIC T 
LYMPHOCYTE ACTIVITY 
 
Cellular immune responses have been postulated to confer protection from HIV infection 
in persons at increased risk due to sexual behaviour 48,49occupational exposure 50, IV drug 
use 51, perinatal exposure 52,53and prostitution 54. 
                 The theory which evolved from these studies suggested that strong cell 
mediated immune responses induced by a predominance of Th1 cytokines would enhance 
protective immunity or favorably modulate established infections. 
                 In a study done on 11 discordant heterosexual and homosexual couples, 
cytotoxic T lymphocyte activity (CTL) was assessed in the seronegative partner by 
generating effector cells against the primary isolates to which that person had been 
exposed. These effector cells were tested against CD4 and CCR5 transfected autologous 
target B cell lines that were infected with a panel of viruses consisting of the primary 
isolate and laboratory isolates. Virus production was measured by p24 antigen. 
Production of p24 from infected B cell lines was lower than from infected autologous 
phytoagglutinin stimulated blasts but the lysis observed in many assays suggested that 
sufficient antigen was present for processing and presentation of T cells. Cytotoxic T cell 
activity against primary viruses were detected in 5(46%) of 11 exposed un-infected 
subjects and there was good concordance between lysis of 
transfected B cell lines and autologous CD4 cells. But among these 5 in whom cytotoxic 
T lymphocyte activity was detected, 4 had partners with undetectable viral loads and all 
infected partners were on anti-retroviral therapy. Three reasons have  
been proposed for the presence of cytotoxic T lymphocyte activity in partners of these 
patients on ART and with low viral loads.  
1. It is possible that these patients who are serpositive would have transmitted 
sufficient viral antigen / virus (potentially replication deficient variant) to their 
negative partner to stimulate CTL. 
2. CTL may have been generated during a previous greater risk relationship and 
been maintained through low grade continuous exposure. 
3. In persons with greater CD4 counts and lower viral loads, the stimulatory capacity 
of the infected CD4 cells would be greater compared to those with advanced 
disease in whom CD4 cells should be lower55. 
 
 
 
 
5.3.6 ANTIBODY DIRECTED AGAINST GENE PRODUCTS OF THE MHC OR 
MHC DISCORDANCE 
 
It has also been proposed that relative resistance to HIV-1 infection may be mediated by 
antibody directed against the gene products of the major histocompatability complex. 
This has been shown to protect macaques from simian immunodeficiency virus .56, 57. 
In babies born to HIV-1 infected mothers, protection from perinatal infection is strongly 
associated with Class 1 MHC discordance between the mother and child58. However in a 
small study with 11 serodiscordant partners, resistance to transmission  
did not significantly co-relate with the degree of MHC discordance between sex 
partners55. 
                 Thereby, many behaviour related and molecular factors have been shown to 
influence transmission of HIV among heterosexual partners. 
. 
                            
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
6.0  MATERIAL AND METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.1 Study setting: 
                  
This study is done in the Christian Medical College Hospital Vellore and its satellite 
clinic at the Low Cost Effective Care Unit. Eligible patients were enrolled from both the 
in and out-patient sections. 
6.2 Study period:  
June 2006 to July 2007 (13 months).  
6.3 Study design: 
 
This is an unmatched case-control study of couples.  
 
6.4 Subjects: 
 
The patients were enrolled as couples in whom HIV infection was newly detected in 
either male partner or female partner or in both. 
Cases: HIV concordant couples. Defined as both married partners being positive. 
Controls: HIV discordant couples. Defined as only one married partner being positive. 
Index or transmitting partner: Defined as the partner acquiring HIV infection first and   
transmitting the virus to the other partner. The probable index partner among the 
concordant couples was determined by looking at 3 criteria – namely: presence of   risk 
factors for HIV acquisition, levels of CD4 counts and advanced clinical stage of disease 
(WHO clinical stage 3 and 4). If one of such partners had any two out of these three 
criteria fulfilled, he or she would be considered the index or transmitting partner. In the 
serodiscordant group, the positive partner was the transmitting partner. 
 
 
  
 
Unsure transmission: Defined as the concordant couples in whom the probable 
transmitting partner could not be ascertained. 
Inclusion criteria: 
The subjects were from rural and sub-urban South India. They should be living together 
as married partners.  
Exclusion criteria: 
1.Subjects from other parts of India.  
2.Married partners who were not living together.  
3.Unmarried partners.  
HIV serostatus was confirmed by doing a dually reactive ELISA or by rapid testing using  
a simple ELISA test on serum. If one of the partners was seronegative, rapid test for HIV 
was repeated at 3 months. 
 
6.5 Enrollment of cases: 
 
Eligible subjects were interviewed by a standard questionnaire (see proforma). Informed 
consent was obtained from each partner separately .They were interviewed on sexual 
behaviour, high risk practices, use of alcohol, smoking, intravenous drug use, condom 
use before and after knowledge of HIV status, genital ulcers, urethro-vaginal discharge, 
diagnosed sexually transmitted diseases and circumcision among males. Demographic 
data was also obtained. Interviews on sexual behaviour and high risk sexual practices  
 
 were done. The patients underwent physical examination and were staged clinically 
according to the WHO staging system (Appendix 1).VDRL test for syphilis was done.  
                    Blood was drawn for CD4 counts. The CD4 lymphocyte counts were 
enumerated at the Benjamin Pulimood Laboratory for Infection and Immunity by BD 
FACSCount system of flowcytometry. This flowcytometer uses a single platform 
methodology to determine absolute CD4 lymphocyte counts. The BD FACSCount 
system is designed to use unlysed whole blood, collected in liquid EDTA.When whole 
blood is added to the tubes of a sample reagent pair, the flurochrome-labeled antibodies 
bind specifically to antigens on the surface of lymphocytes. The BD FACSCount 
instrument detects two fluorescent colours and measures relative cell size. CD3 cells 
fluoresce red and CD4 and CD8 cells fluoresce yellow when analysed on the BD 
FACSCount instrument. A known number of reference beads is contained in each reagent 
tube and functions as fluorescence and quantitation standard for calculating the absolute 
counts for CD4+, CD8+ and CD3+ T lymphocytes. Fixative solution is added to the 
stained samples prior to analysis to preserve the integrity of the antibody binding. No 
lysing is necessary. When the sample tubes are run on the system, analysis is 
automatically completed by the system with no user intervention. The automated analysis 
is done in 5 steps. First the threshold is positioned to eliminate small signal events, such 
as debris, erythrocytes, platelets, monocytes and granulocytes. Then a fixed number of 
events is acquired. Second, the bead and cell populations are located in two dimensions: 
red vs. yellow. Third, ellipses are placed around the cell and bead populations, with the 
control run providing the starting point. The ellipses optimize their position based on the 
centre of each population. Fourth, an orbital region is placed around each ellipse. Lastly, 
additional events are collected, up to 30,000 per sample, so that precision of the 
measurement is not limited by statistical sampling variation. The data is then processed 
and reported. Absolute counts are determined by a simple ratio: 
Observed counts from the population of interest ⁄ Observed reference bead counts * 
Reference bead count ⁄ µl whole blood. 
 
 
6.6 Variables studied:  
The demographic variables studied were age, occupation, education, income per month, 
domicile, duration of marriage and number of children. Variables studied regarding 
sexual behaviour patterns were the number of sexual partners other than spouse, duration 
since last sexual exposure to any person other than spouse, receipt of any blood 
transfusion, intravenous drug abuse, cigarette smoking, alcohol consumption, frequency 
per month of sexual intercourse before knowledge of HIV serostatus and after, frequency 
of condom use per month, use of other contraceptive practices, previous and current 
genital ulcers, previous and current urethro-vaginal discharge, diagnosis of previous or 
current sexually transmitted disease, circumcision in the male partner. Clinical stage of 
HIV disease, CD4 lymphocyte counts and VDRL test results were recorded. 
 
 
 
  
 6.7 Sample size calculation: 
           Sample size was estimated according to the following formula: 
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P2 is the proportion of “never used condoms” among the concordant couples 
 
P1 is the proportion in the discordant couples 
 
2/αZ  is 1.96 at 5% alpha level 
 
β−1Z is 1.282 for 90% power 
 
The required sample size was calculated as 109 cases and 109 controls with a 5% alpha 
level and 90% power. 
               
6.8 Statistical analysis: 
 
 All statistical analysis was done using the Statistical Package for the Social Sciences 
(SPSS) software version 15. Chi-square test was used for comparison of categorical 
variables. Odds Ratio (OR), confidence intervals were calculated and a ‘p’ value less than 
0.05 was considered statistically significant. All reported p values are two-sided. 
Univariate logistic regression models were constructed with sero-concordance as the 
dependent variable to determine the risk of transmission. Variables with p < 0.20 in the 
univariate model were entered in the multivariate model. Also those variables that could 
possibly be significant were used in the multi-variate analysis. 
HIV concordant and discordant couples were compared for each of these variables and 
the risk of transmission for each variable calculated using odds ratio’s. Their significance 
was determined using p values and 95% confidence intervals. 
Analysis was also done according to the possible mode of transmission of HIV (that is 
male to female or female to male). were classified as unsure transmission and analysed 
separately. 
  
6.9 Funding: 
This study was approved and funded by the Fluid Research Committee (No 5905) dated 
20.6.06 of Christian Medical College, Vellore. 
 
6.10 Ethical clearance: 
Ethics committee clearance was not obtained as this study did not involve any 
intervention. However all patients signed informed consent documents individually. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
7.0  RESULTS 
 
 
 
 
 
 
 
 
 
 
 
 
7.0 RESULTS 
 
 
A total of 224 patients that included 112 married couples living together since either 
partner was detected to be infected with HIV, were enrolled. Among these 224, 168 were 
HIV infected of which 112(i.e. 56 couples had HIV concordance).In the remaining 112 
patients, 56 were HIV seronegative and they had HIV infected partners(i.e.56 couples 
were serodiscordant) . 
 
 
7.1 DEMOGRAPHY  
 
7.1.1 AGE: 
 
The mean age of the males were 37.6 and 39.3 years in the concordant and discordant 
groups respectively. The mean ages of the females were 30.7 and 32.2 among concordant 
and discordant groups respectively. 
                     Figure 1: shows the age distribution  of 112 male partners       
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          Figure 2: shows the age distribution of 112 female partners 
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7.1.2 DOMICILE: 
 
                    Patients from TamilNadu constituted 66.1%. Patients from Andhra Pradesh 
31.2% and Karnataka 2.7%. 
                                                                  
      Figure 3: shows the distribution of domicile of 56 concordant couples     
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Figure 4: shows the distribution of domicile of 56 discordant couples 
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7.1.3 OCCUPATION: 
 
      
                         Figure 5: shows the distribution of occupation of 112 males 
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Figure 6: shows the distribution of occupation of 112 females 
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7.1.4 EDUCATION: 
               87.7% of the men and 84.8% of the women were educated. 
              Figure 7: shows the distribution of educational qualification of 112 males                                    
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   Figure 8: shows the distribution of educational qualification of 112 females 
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7.1.5 SOCIO-ECONOMIC STATUS:    
  
      83.9% of families with discordant couples and 87.5% with concordant couples 
belonged to the lower socio-economic category, their income being < Rs.5000/month  
Among the women who worked, 66.7% earned <Rs.1000/month. 
                        Figure 9: shows the income distribution of 112 families                
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7.1.6 YEARS OF LIVING TOGETHER AS MARRIED COUPLES: 
 
65.3% of the couples had been married for 10 years or less. 
 
 
 
 
TABLE 3: SHOWS THE DISTRIBUTION OF  DEMOGRAPHIC CHARACTERISTICS OF 56 
CONCORDANT AND 56 DISCORDANT COUPLES  
 
Seri
al 
No. 
DEMOGRAPHIC 
VARIABLES 
DISCORDANT 
MALES 
n=56   (%) 
DISCORDANT 
FEMALES 
n=56    (%) 
CONCORDANT 
MALES 
n=56    (%) 
CONCORDANT 
FEMALES 
n=56    (%) 
1 Age     
 <=34 13(23.2) 35(62.5) 19(33.9) 45(80.3) 
 35-44 32(57.1) 16(28.6) 30(53.6) 7(12.5) 
 >=44 11(19.6) 5(8.9) 7(12.5) 4(7.1) 
2 Occupation     
 Unskilled 22(39.3) 53(94.6) 27(48.2) 51(91.1) 
 Skilled 33(58.9) 3(5.4) 29(51.8) 5(8.9) 
3 Education     
 None 3(5.3) 4(7.1) 7(12.5) 8(14.3) 
 School 42(75) 44(78.6) 45(80.3) 42(75) 
 Graduate/postgraduate 8(14.3) 4(7.1) 4(7.1) 5(8.9) 
4 Income     
 None  45(80.3)  43(76.8) 
 <1000 12(21.4) 7(12.5) 16(28.6) 9(16) 
 1000-5000 35(62.5) 4(7.1) 33(58.9) 4(7.1) 
 >5000 9(16)  7(12.5)  
5 Domicile   
 TamilNadu 41(73.2) 33(58.9) 
 AndhraPradesh 13(23.2) 22(39.3) 
 Karnataka 2(3.6) 1(1.8) 
6 Number of children   
 None 9(16.1) 12(21.4) 
 1 9(16.1) 11(19.6) 
 2 24(42.9) 25(44.6) 
 >2 14(25) 8(14.3) 
 
 
 
TABLE 4: SHOWS THE DISTRIBUTION OF FACTORS INFLUENCING TRANSMISSION AMONG 56 
DISCORDANT AND CONCORDANT COUPLES (n=224) 
 
 
Serial 
No. 
FACTORS 
AFFECTING 
TRANSMISSION 
DISCORDANT 
MALES 
n=56   (%) 
DISCORDANT 
FEMALES 
n=56    (%) 
CONCORDANT 
MALES 
n=56    (%) 
CONCORDANT 
FEMALES 
n=56    (%) 
1 Duration of marriage     
 <2 years 2(3.6) 4(7.1) 
 2-5 6(10.7) 6(10.7) 
 6-10 17(30.3) 21(37.5) 
 >10 31(55.3) 25(44.6) 
2 Other sex partners     
 None 15(29.4) 4(80)   
 1 13(25.5) 1(20)   
 >1 23(45.1)    
3 Duration since last exposure     
 None 20(35.7) 55(98.2) 17(30.3) 54(96.4) 
 <6 months 1(1.8)  1(1.8) 2(3.6) 
 7-12 months 5(8.9)  0  
 >1 year 30(53.6) 1(1.8) 38(67.8)  
4 Clinical stage     
 1 20(35.7) 1(1.8) 25(44.6) 45(80.3) 
 2 3(5.3) 2(3.6) 3(5.3) 1(1.8) 
 3 18(32.1) 1(1.8) 24(42.8) 4(7.1) 
 4 9(16) 0 4(7.1)  
5 CD4 count     
 <200 20(35.7) 1(1.8) 28(50) 15(26.8) 
 200-350 11(19.6) 1(1.8) 16(28.6) 11(19.6) 
 >350 16(28.6) 2(3.6) 6(10.7) 22(39.3) 
6 Anti-retroviral use     
 No 49(87.5) 4(7.1) 53(94.6) 55(98.2) 
 Yes 2(3.6) 1(1.8) 3(5.4) 1(1.8) 
7 Condom use     
 absent 52(92.8) 53(94.6) 
 present 4(7.2) 3(5.4) 
8 Blood transfusion     
 No 54(96.4) 53(94.6) 54(96.4) 54(96.4) 
 Yes 2(3.6) 3(5.4) 2(3.6) 2(3.6) 
9 IV drug use     
 No 56(100%) 56(100) 54(96.4) 56(100) 
 Yes 0  2(3.6)  
10 Smoking     
 No 38(67.9) 56(100) 30(53.6) 56(100) 
 Yes 18(32.1)  26(46.4)  
 
 
 
 
 
TABLE 4: SHOWS THE DISTRIBUTION OF FACTORS INFLUENCING TRANSMISSION AMONG 56 
DISCORDANT AND CONCORDANT COUPLES (n=224) (CONTD) 
 
 
 
Serial 
No. 
FACTORS 
AFFECTING 
TRANSMISSION 
DISCORDANT 
MALES 
n=56   (%) 
DISCORDANT 
FEMALES 
n=56    (%) 
CONCORDANT 
MALES 
n=56    (%) 
CONCORDANT 
FEMALES 
n=56    (%) 
11 Alcohol     
 0 30(53.6) 56(100) 22(39.3) 56(100) 
 1-2/week 12(21.4)  10(17.8)  
 3-5/week 5(8.9)  10(17.8)  
 daily 9(16)  14(25)  
12 Past genital ulcers     
 9. 41(73.2) 51(91) 36(64.3) 44(78.6) 
 Yes 15(26.8) 5(8.9) 20(35.7) 12(21.4) 
13 Present genital ulcers     
 No 50(89.3) 55(98.2) 53(94.6) 54(96.4) 
 Yes 6(10.7) 1(1.8) 3(5.4) 2(3.6) 
14 Past urethro-vaginal discharge     
 No 50(89.3) 48(85.7) 44(78.6) 40(71.4) 
 Yes 6(10.7) 8(14.3) 12(21.4) 16(28.6) 
15 Present urethro-vaginal discharge     
 No 55(98.2) 51(91.1) 56(100) 46(82.1) 
 Yes 1(1.8) 5(8.9) 0 10(17.9) 
16 Past STI     
 None 53(94.6) 56(100) 52(92.8) 54(96.4) 
 Herpes   3(5.4) 1(1.8) 
 Syphilis 3(5.4)  1(1.8)  
 Candida    1(1.8) 
17 Present STI     
 None 54(96.4) 55(98.2) 54(96.4) 53(94.6) 
 Herpes 1(1.8) 1(1.8) 1(1.8)  
 Syphilis 1(1.8)    
 Candida    3(5.4) 
 Warts   1(1.8)  
16 VDRL     
 Reactive 2(3.6)  1(1.8) 1(1.8) 
 Non-reactive 33 32 36 38 
17 Circumcision     
 yes 3(5.4)  2(3.6)  
 no 53  54  
 
 
 
 
 
 
7.2 FACTORS AFFECTING TRANSMISSION: 
 
 
7.2.1 AGE: 
            
          Husband’s age being ≤34 years is associated with an OR  2.30 (95% CI 0.71-7.49; 
p=0.17) for the couple being HIV concordant. 
        
        Wife’s age ≥35 years is associated with an odds 2.18 (95% CI 0.93-1.02; p=0.33) for 
the couple being concordant. 
                  
 7.2.2. OCCUPATION: 
 
                      Having an unskilled occupation is associated with an OR 1.40 (95% CI 
0.66-2.96; p=0.38) in men and OR 0.42 (95% CI 0.16-1.15; p=0.09) among women for 
HIV transmission. 
 
7.2.3. INCOME: 
              The risk of HIV transmission for those who earned <Rs.1000/month is OR 0.7 
(p=0.36) and is 1.7 (p=0.38) for those who earned between Rs.1000 and 5000 /month. 
 
7.2.4. EDUCATION: 
 
              School educated males have a risk of HIV transmission OR 4.66 (95% CI 0.77-
28.45; p=0.09).Graduates and post-graduates have an OR 2.14 (95% CI 0.60 –  
 
7.64; p=0.24). A similar increased risk 1.60 (95% CI 0.27-9.28; p=0.6) is found among 
females who were school educated. Female graduates and post-graduates have an OR 
0.76 (95% CI 0.19-3.03; p=0.70) for transmission. 
 
 
7.2.5. YEARS OF LIVING TOGETHER: 
 
                The risk of acquiring HIV infection is 0.97 (95% CI 0.93-1.02; p=0.27) for 
each additional year of living together. 
       
 
7.2.6. NUMBER OF CHILDREN: 
 
                 In couples who had one child the OR for transmission is 0.91(95% CI 0.26-
3.14; p=0.89). Couples who have two children or more have a risk of 0.78 (95% CI 0.27-
2.18; p=0.63) and 0.42 (95% CI 0.12-1.45; p=0.17) for transmission. 
 
 
7.2.7. OTHER SEX PARTNERS: 
 
               The risk for reported intercourse with partners other than spouse is 0.84 (95% 
CI 0.49-2.49; p=1.09) for men and 2.03(95% CI 0.18- 23.13; p=0.57) for women. 
                 
7.2.8 LAST EXPOSURE:  
 
              Male patients who had their last sexual exposure with a person other than spouse 
more than a year ago have a risk of 1.11(95% CI 0.85-1.45; p=0.45) for HIV concordance 
compared to those who had their last exposure outside marriage less 
 
 
 than a year ago. Females have an OR 0.83 (95% CI 0.24- 2.84; p=0.76) for transmission 
if their last exposure outside marriage was more than one year ago. 
 
 
7.2.9 BLOOD TRANSFUSION:  
 
                 Previous blood transfusion in males and females is associated with an OR 1 
(95% CI 0.14-7.36; p=1.0) and 0.65 (95% CI 0.11-4.07; p=0.65) respectively for HIV 
transmission. 
             
 
7.2.10 IV DRUG USE: 
             
                 Only 2 men among concordant couples reported IV drug use. OR 2E+009; 
 p=0.99 
 
 
7.2.11 SMOKING:  
 
                 Smoking in the husband was associated with a risk of 1.83 (95% CI  0.85-3.95; 
p=0.12) for HIV transmission. 
 
 
7.2.12 ALCOHOL: 
             
                 Fewer males among discordant couples [26 (46.43%)] consumed alcohol than 
concordant couples [34 (60.71%)]. Consumption of 3 or more drinks per week and 
drinking daily were associated with a risk of 2.72(95% CI 0.82-9.11; p=0.10) and 
2.12(95% CI 0.78-5.78; p=0.14) for HIV transmission. 
 
7.2.13 CLINICAL STAGING: 
                        
               Males who had a WHO clinical stage of 3 and 4 have a risk of 1.08(p=0.83) for 
transmitting HIV compared to males in stages 1 and 2  
                    
 
7.2.14 CD4 LYMPHOCYTE COUNT: 
                       
                Males whose CD4 lymphocyte counts were < 200/mm3 and 200-350/mm3 have 
an OR 3.73 (p=0.02) and 3.88 (p=0.03) for HIV transmission respectively. 
                Females whose CD4 lymphocyte counts were < 200/mm3 and 200-350/mm3 
have an OR 1.36 (p=0.80) and 1 (p=1.0) for HIV transmission respectively.    
                     
                        
7.2.15 ANTI-RETROVIRAL USE: 
                          
              Males who were not on ART had a risk of 1.38 (95% CI 0.22-8.65; p=0.73) for 
HIV transmission. The risk was 0.07 (95% CI 0.00-1.39; p=0.08) in females who were 
not on ART. 
             
7.2.16 FREQUENCY OF INTERCOURSE PRIOR TO SERODETECTION: 
 
              An increase in the frequency of sexual intercourse by 1/month increased the risk 
of HIV transmission by 1.042 (95% CI 0.999-1.087; p=0.05). 
 
7.2.17 FREQUENCY OF INTERCOURSE AFTER SERODETECTION: 
                      
            Decreased frequency of intercourse of < 2/month was associated with a 36% 
lower chance of HIV transmission. Increased frequency of intercourse ≥ 2/month was 
associated with a risk of 1.39 (p=0.37) for transmission. 
 
 
7.2.18 CONDOM USE: 
 
              Condom use lowered the risk of HIV transmission by 35% (95% CI 0.17-2.45; 
p=0.52). 
 
                     
7.2.19 OTHER CONTRACEPTIVES: 
 
       Use of other non-barrier contraceptive methods had a protective effect of 32% on 
transmission.                  
 
Table 5 shows the number of patients using contraceptives other than condoms 
 
 Frequency (%)Concordant 
Frequency (%)
Discordant 
Tubectomy 7(46.7) 8(53.3) 
OCP’s 0 1(100) 
Copper T 1(33.3) 2(66.7) 
 
 
 
7.2.20 PREVIOUS GENITAL ULCERS : 
   
           History of previous genital ulcers is associated with an OR 1.52 (95% CI 0.68 – 
3.40; p=0.31) for transmission in males and an OR 2.78 (95% CI 0.91-8.51; p=0.07) for 
transmission in females. 
 
 
7.2.21 CURRENT GENITAL ULCERS : 
         
         Presence of genital ulcers in the male at the time of detection of HIV infection is 
associated with a risk of 0.47 (95% CI 0.11-1.99; p=0.31) for transmission. The risk of 
transmission in females who had active genital ulcer disease is 2.04 (95% CI 0.18 – 
23.13; p=0.57). 
   
7.2.22 PREVIOUS URETHRO – VAGINAL DISCHARGE : 
 
         Previous urethral discharge in males is associated with a risk of 2.27 (95% CI 0.79-
6.56; p=0.13) for transmission. The risk of HIV transmission in females with urethral or 
vaginal discharge is 2.40 (95% CI 0.93-6.18; p=0.07). 
  
 
7.2.23 CURRENT URETHRO – VAGINAL DISCHARGE : 
  
             Current active UV discharge in the female is associated with an increased risk of 
2.22 (95% CI 0.71-6.97; p=0.17) for HIV transmission. 
 
 
7.2.24 PREVIOUS SEXUALLY TRANSMITTED DISEASE: 
   
              Presence of syphilis in the husband is associated with a risk of 0.34 (p 0.36) for 
transmission. 
 
 
7.2.25 CURRENT SEXUALLY TRANSMITTED DISEASE: 
                 
           Active genital herpes is associated with a risk of 1(95% CI 0.06-16.40; p=1.0) for 
transmission. 
 
 
 
 
 
7.2.26 VDRL POSITIVITY : 
                       
         Only one concordant couple and 2 males among the discordant couples had a 
positive VDRL test. Being VDRL non-reactive has a 54% protective effect from HIV 
transmission. 
 
 
7.2.27 CIRCUMCISION : 
 
            Males who were circumcised have a 35% lesser chance of transmitting HIV 
infection than whose who did not (95% CI 0.11-4.07; p=0.65). 
 
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MULTIVARIATE ANALYSIS 
 
On multivariate analysis, the only variable that affected transmission significantly was 
the CD4 count of the husband. A CD4 count of < 200 was associated with an odds ratio 
of 4.24 (95% CI 1.20-14.93; p=0.02) .A CD4 count between 200 – 350 was associated 
with an odds ratio of 4.15 (95% CI 1.05 -16.40; p=0.04). 
 
Table 6 Data of multivariate analysis 
 
 
 
 
 
 
 
 
VARIABLES Odds ratio P value 95% CI 
IV drug use 
husband 
7E+008 0.99 0.00 
Smoking-husband 2.21 0.09 0.88-5.59 
CD4 husband<200 4.24 0.02 1.20-14.93 
CD4 husband 200-350 4.15 0.04 1.05-16.40 
Age husband 0.97 0.63 0.86-1.09 
Age wife 1.01 0.86 0.90-1.13 
Present discharge husband 0.00 1.00 0.00 
Present discharge wife 1.21 0.80 0.28-5.20 
Present STI wife 1.85 0.32 0.55-6.26 
Present STI husband 1E+009 0.99 0.00 
  
 
 
TABLE 7:  DISTRIBUTION OF FACTORS INFLUENCING TRANMISSION AMONG 56 DISCORDANT 
AND CONCORDANT COUPLES BASED ON THE PROBABLE MODE OF TRANSMISSION: 
 
Serial 
No. 
FACTORS 
INFLUENCING 
MODE OF 
TRANSMISSION 
DISCORDANT 
MALE 
PARTNER + 
(n=51) (%) 
DISCORDANT 
FEMALE 
PARTNER + 
(n=5) (%) 
CONCORDANT 
MÆF (n=33) (%) 
CONCORDANT 
FÆM (n=7) (%) 
1 Duration of marriage     
 <2 years 3(5.8) 0 1(3) 0 
 2-5 6(11.7) 0 3(9) 0 
 6-10 16(31.3) 1(20) 12(36.3) 4(57.1) 
 >10 26(50.9) 4(80) 17(51.5) 3(42.9) 
2 Other sex partners     
 None 15(29.4) 4(80) 7(21.2) 6(85.7) 
 1 13(25.5) 1(20) 10(30.3) 1(14.3) 
 >1 23(45.1)  16(48.5)  
3 Clinical stage     
 1 21(41.2) 2(40) 4(12.1) 1(14.3) 
 2 3(5.9) 2(40) 3(9.1) 0 
 3 18(35.3) 1(20) 22(66.7) 2(28.6) 
 4 9(17.6) 0 4(12.1) 4(57.1) 
4 CD4 count     
 <200 20(39.2) 1(20) 24(72.7) 7(100) 
 200-350 11(21.6) 1(20) 6(18.2) 0 
 >350 16(31.4) 2(40) 0 0 
5 
Past ulcers 
transmitting 
partner 
    
 absent 36(70.6) 5(100) 25(75.8) 2(28.6) 
 present 15(29.4) 0 8(24.2) 5(71.4) 
6 Past ulcers acquiring partner     
 absent 46(90.2) 5(100) 29(87.9) 2(28.6) 
 present 5(9.8) 0 4(12.1) 5(71.4) 
7 
Present ulcers 
transmitting 
partner 
    
 absent 45(88.2) 5(100) 32(97) 6(85.7) 
 present 6(11.8) 0 1(3) 1(14.3) 
8 Present ulcers acquiring partner     
 absent 50(98) 5(100) 32(97) 6(85.7) 
 present 1(2) 0 1(3) 1(14.3) 
      
Serial 
No. 
FACTORS 
INFLUENCING 
MODE OF 
TRANSMISSION 
DISCORDANT 
MALE 
PARTNER +  
(n=51) (%) 
DISCORDANT 
FEMALE 
PARTNER + 
 (n=5) (%) 
CONCORDANT 
MÆF (n=33) (%) 
CONCORDANT 
FÆM (n=7) (%) 
9 
Past discharge 
transmitting 
partner 
    
 absent 46(90.2) 5(100) 27(81.8) 3(42.9) 
 present 5(9.8) 0 6(18.2) 4(57.1) 
10 Past discharge acquiring partner     
 absent 43(84.3) 5(100) 26(78.8) 4(57.1) 
 present 8(15.7) 0 7(21.2) 3(42.9) 
11 
Present discharge 
transmitting 
partner 
.    
 absent 50(98) 5(100) 33(100) 4(57.1) 
 present 1(2) 0 0 3(42.9) 
12 Present discharge acquiring partner     
 absent 46(90.2) 5(100) 29(87.9) 7(100) 
 present 5(9.8) 0 4(12.1) 0 
13 Anti-retroviral therapy 2(3.9) 1(20) 1(3) 0 
14 VDRL reactive 2(3.9) 0 1(3) 0 
15 Circumcision 2(3.9) 1(20) 2(6) 0 
16 Previous STI     
 Syphilis 3(5.9) 0 1(3) 0 
 Genital herpes 0 0 2(6) 0 
 Vaginal candidiasis 0 0 1(3) 0 
17 Present STI     
 Syphilis 1(2)    
 Genital herpes 1(2)  1(3)  
 Vaginal candidiasis   1(3) 1(14.3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 8: SHOWS THE DISTRIBUTION OF FACTORS INFLUENCING TRANSMISSION IN 16 
COUPLES IN WHOM TRANSMISSION WAS UNSURE 
 
 
 
Serial 
No. VARIABLE 
CONCORDANT 
TRANSMISSION
UNSURE-MALE 
CONCORDANT 
TRANSMISSION 
UNSURE-FEMALE 
1 Duration of marriage  
 <2 years 3 
 2-5 years 3 
 6-10 years 6 
 >10 years 4 
2. Other sex partners   
 None 8(50) 16(100) 
 1 0 0 
 >1 8(50) 0 
3. Clinical stage   
 1 14(87.5) 13(81.3) 
 2 0 0 
 3 2(12.5) 2(12.5) 
 4 0 1(6.2) 
4. CD4 count   
 <200 3(18.8) 6(37.5) 
 200-350 6(37.5) 5(31.2) 
 >350 4(25) 3(18.8) 
5. Past genital ulcers   
 absent 9(56.2) 13(81.2) 
 present 7(43.8) 3(18.8) 
6. Present genital ulcers   
 absent 15(93.8) 16(100) 
 present 1(6.2) 0 
7. Past discharge   
 absent 13(81.2) 11(68.8) 
 present 3(18.8) 5(31.2) 
8. Present discharge   
 absent 16(100) 13(81.2) 
 present 0 3(18.8) 
9. Previous STI   
 Herpes 1(6.2) 1(6.2) 
10. Present STI   
 Warts 1(6.2)  
 Candidiasis  1(6.2) 
11. Anti-retroviral therapy 2(12.4) 1(6.2) 
12. VDRL reactive 0 0 
13. Circumcision 0 0 
 
 
 
 
Longer duration of marriage was associated with higher rates of HIV transmission. But 
there was an equally large number of patients who had been married for >10 years in the 
group that had not yet transmitted the infection. 
 
The risk of HIV transmission from male to female among those with clinical stage 3 and 
4 compared to 1 and 2 was 2.17( 95% CI 1.07-4.40) . 
 
The risk of HIV transmission from female to male was 3.42 (95% CI 0.61-19.22) for 
those with stage 3 and 4 compared to stage 1 and 2. 
 
Among the concordant group, 5 were asymptomatic transmitting partners (4 male and 1 
female).Among the discordant group,22 were asymptomatic transmitting partners ( 21 
male and 1 female). 
 
None had a clinical stage of 1 or 2 along with a CD4 count of >350, used condoms and 
yet transmitted infection. However, 21(37.5%) of the index partners had a clinical stage 
of 3 or 4 along with a CD4 count of <350, never used condoms and did not transmit the 
infection. 
 
The number who had blood transfusion alone as the sole mode of transmission was 1 in 
the concordant group (where the probable mode of transmission was from male to 
female) and 4 in the discordant group, one in which the male was the index partner and 
three where the female was the index partner. 
 
7.3 FACTORS ASSOCIATED WITH HIV SERODISCORDANCE 
 
7.3.1 SOCIAL FACTORS: 
7.3.1.1 ALCOHOL: 
              Alcohol consumption is significantly lower in the discordant group 42.4% 
compared with 57.6% in the concordant group and lesser alcohol consumption has an 
odds of 1.2 for discordance. 
 
7.3.1.2 SMOKING: 
                The number of males who smoked is lower in the discordant group 40.9% 
vs. 59.1% in the concordant group. Lesser smoking had odds of 1.2 for discordance. 
7.3.2 BEHAVIOURAL FACTORS: 
7.3.2.1 DURATION OF MARRIAGE: 
                     The number of discordant couples who were married for <5 years are 
more than the number of concordant couples married for the same duration 69.2% vs. 
30.8% but this does not have a significant effect on transmission ( OR 0.85 ; 95% CI 
0.56-1.28 ). 
 
 
 
7.3.2.2 PREVIOUS GENITAL ULCERS: 
              This is associated with an OR of 0.9 for discordance. 
 
7.3.2.3 CURRENT GENITAL ULCERS: 
              The OR for discordance is 0.7 
 
7.3.2.4 PREVIOUS URETHRO-VAGINAL DISCHARGE: 
              Past discharge is  associated with an odds of 1.3 for non-transmission. 
 
7.3.2.5 PRESENT URETHRO-VAGINAL DISCHARGE: 
              This has an OR 0.6 for HIV discordance 
 
7.3.2.6 CLINICAL STAGE OF DISEASE: 
               Stage of disease of 1or 2 is associated with an OR 1.5 for discordance. 
 
7.3.2.7 CD4 COUNT:  
               CD 4 count > 350 is associated with an OR of 1.9 for discordance. 
 
We found that 30 couples who were HIV serodiscordant had lived together for more 
than 10 years and yet not transmitted HIV to the uninfected partner. To study the 
factors which protected them from such transmission, they were compared with 24 
HIV seroconcordant couples who had also lived as partners for more than 10 year 
duration. There was a lower frequency of sexual intercourse prior to serodetection(i.e 
<5 episodes per month) in the discordant group compared to concordant [73% 
vs.50%] and an increase in condom use after serodetection [23.3% vs.8.4%].23.1% of 
the serodiscordant males had CD4 lymphocyte counts more than 350 cells compared 
to 12.5% of the concordant males. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8.0  DISCUSSION 
 
 
 
 
 
 
 
 
HIV transmission is known to be affected by several factors. There are a large number of 
HIV sero-discordant partners in whom transmission does not occur despite several years 
of living in partnership. In a cross-sectional study done in Chennai, this number was 
reported to be 44%.4   
                    This study was there-fore done to identify the risk factors for HIV 
transmission and to identify factors which protect against transmission by comparing the 
group in which transmission has already occurred (concordant) with the group in which 
transmission to the spouse has not yet occurred.  
Social factors: 
               Regular alcohol consumption was associated with an increased the risk of HIV 
transmission. This has been shown before in several studies. For men, heavier alcohol use 
is known to be associated with having multiple sex partners in the past month, less 
condom use, and having a history of sexually assaulting women. 59, 60.  
               Smoking is also associated with an increased risk of HIV transmission. Lesser 
alcohol consumption and smoking had a protective effect of 12% for discordance. 
               Intravenous drug use is not prevalent in this cohort of patients studied as only 2 
males who were in a seroconcordant partnership had been abusing IV drugs. The female 
was the probable index partner in one such partnership and in the other, we are unsure of 
the probable mode of transmission. 
Sexual behavioural patterns: 
              The women who had other sex partners outside the marital  relationship  had an 
increased risk of HIV acquisition. This was probably due to the greater chance of 
acquiring the disease in women due to the favourable large surface area of the vaginal 
mucosa which contains more number of host cell macrophages ,Langerhan’s and 
dendritic cells needed for the virus to be transmitted8 and the presence of a low pH which 
is favourable for virus replication.61 
                Risk of HIV seroconversion was higher for those who had their last sexual 
exposure with a person other than spouse more than a year ago. The risk of HIV 
acquisition did not significantly increase with the duration of living in partnership or with 
more number of children. Increased frequency of intercourse increased the risk of HIV 
transmission and use of condoms regularly had a 35% protective effect. 
            Previous genital ulcers in both partners and current ulcers in females was 
associated with an increased risk for transmission. Similarly, urethro-vaginal discharge in 
both partners had an increased risk for transmission. However, the number of diagnosed 
STI’s were low. Therefore these ulcers could represent those due to trauma or other 
causes and not necessarily implicate an STI.  
            Circumcision in the male partner provided a 35% protective effect from acquiring 
HIV. 
Clinical stage of HIV disease:  
                Increased transmission occurred at advanced clinical stage of disease (WHO 
stage 3 and 4 compared to 1 and 2). Stage 3 and 4 disease is the group in which we 
expect the viral loads to be higher and therefore facilitate transmission. 
CD4 lymphocyte counts: 
                This study found that CD4 counts <350 in male partners were significantly 
associated with risk of acquiring HIV. This could indirectly reflect the fact that higher 
viral loads present in such people with low CD4 counts influences transmission. This 
supports the current recommendation that ART be initiated at CD4 lymphocyte counts < 
350 cells/mm3. 
Use of antiretroviral agents: 
              Only 4 patients -3 discordant and 1 concordant were on ART. This was because 
many of the patients were recently detected to be HIV infected and had not been initiated 
on ART. Also, around 50% of the patients had an early stage of HIV disease. Therefore, 
they were not initiated on ART. 
                  This study was limited by the numbers of couples included. Many of the 
factors were not statistically significant because of the lesser numbers studied. It is 
therefore planned to continue the study to enroll 109 concordant and 109 discordant 
couples. 
                  The main implication of this study is to prevent HIV transmission by 
counseling partners on safe sexual practices, regular use of barrier contraceptives-mainly 
condoms, lesser indulgence in alcohol, identification of genital ulcers and seeking 
appropriate medical help. Also, early initiation of antiretroviral therapy at CD4 
lymphocyte counts < 350 cells/mm3 would prevent HIV transmission to the un-infected 
partner.  
 
  
                         
             
 
      
                                           
                                                 
                                     
 
 
                                                                  
   
      
 
9. 0 CONCLUSION 
 
 
 
 
 
                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 9.1  The social factor affecting HIV transmission is alcohol consumption in the 
male. 
9.2  The sexual behaviour factors affecting transmission were sex with partners 
other than spouse, past or present genital ulcer disease and urethro-vaginal 
discharge. 
9.3  The risk of transmission increased with an advanced clinical and immunological 
stage of disease. 
9.4   Lower frequency of sexual intercourse, regular use of barrier contraception 
prevented HIV transmission among those serodiscordant couples living together 
for a period of more than 10 years. Therefore, counseling on safe sexual 
practices including reduction of frequency of intercourse and regular use of 
condoms should be intensified. 
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11.0 PROFORMA 
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COUPLE NAME: 
 
COUPLE HOSPITAL NUMBER:  
                               
QUESTIONNAIRE ADMINISTERED  TO  MALE / FEMALE  PARTNER: 
 
Name-                      
 
Age   -                                                                                     
 
Sex   -    
                                                                                     
Occupation-                                                                               
 
Education-  none / school / graduate / post-graduate. 
 
Income per month - <1000 / 1000-5000 / 5000-10,000 / >10,000 
                                                                                
Address- 
 
Living together or not-                                       Yes/No 
 
No. of years of living together- 
 
No of children- 
 
HIV status of patient-                                                                              
 
Time since detection of serostatus-                                                             
 
Any other sexual partners till date-                                                        
 
Number of other sexual partners till date-                                                     
 
Time since last sexual exposure 
outside this relationship       -      <6 months/7 months -1 year/>1 year. 
 
Any blood transfusions-                                                               
 
Any IV drug use-   
 
Smoking -     present/absent. 
 
Alcohol- (number of drinks per week) - 1-2 / 3-5 / drinks everyday.  
 
                                                                    
 
Clinical staging of disease-                                                          
 
CD 4  count-                                                                               
 
Any anti-retro viral medications taken-   
 
                                 
FREQUENCY OF SEXUAL INTERCOURSE BEFORE HIV STATUS KNOWN- 
 
No. of episodes of sexual intercourse per month- 
 
No. of episodes in which condoms were used per month- 
 
FREQUENCY OF SEXUAL INTERCOURSE AFTER HIV STATUS IS KNOWN- 
 
No. of episodes of sexual intercourse per month- 
 
No. of episodes in which condoms were used per month – 
 
Any other contraceptive practices followed-       Yes/No 
 
If yes, what - OCP’s / barrier methods / spermicides 
 
Presence of ulcerative genital lesions in the past- 
 
Presence of ulcerative genital lesions at present –  
 
History of urethral/vaginal discharge in the past- 
 
History of urethral/vaginal discharge at present- 
 
Any particular diagnosis made for the previous STI- 
 
History of treatment received for the same- 
 
Diagnosis of current STI- 
 
VDRL status-                                                                        
 
Circumcision in male partner- 
 
No. of joint counseling sessions- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12. APPENDIX 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12.1   APPENDIX 1: WHO CLINICAL STAGING OF HIV DISEASE 
 
 
 
 
Primary HIV Infection 
 Asymptomatic  
 Acute retroviral syndrome 
Clinical Stage 1 
 Asymptomatic  
 Persistent generalized lymphadenopathy 
Clinical Stage 2 
 Moderate unexplained weight loss (<10% of presumed or measured body weight)  
 Recurrent respiratory infections (respiratory tract infections, upper respiratory infections, 
sinusitis, bronchitis, otitis media, pharyngitis)  
 Herpes zoster  
 Minor mucocutaneous manifestations (angular cheilitis, recurrent oral ulcerations, 
seborrheic dermatitis, prurigo, papular pruritic eruptions, fungal fingernail infections) 
Clinical Stage 3 
Conditions for which a presumptive diagnosis can be made on the basis of clinical signs or simple investigations 
 Severe weight loss (>10% of presumed or measured body weight)  
 Unexplained chronic diarrhea for >1 month  
 Unexplained persistent fever for >1 month (intermittent or constant)  
 Oral candidiasis (thrush)  
 Oral hairy leukoplakia  
 Pulmonary tuberculosis within the last 2 years  
 Severe presumed bacterial infections (eg, pneumonia, empyema, pyomyositis, bone or 
joint infection, meningitis, bacteremia)  
 Acute necrotizing ulcerative stomatitis, gingivitis or periodontitis 
Conditions for which confirmatory diagnostic testing is necessary 
 Unexplained anemia (hemoglobin <8 g/dL)  
 Neutropenia (neutrophils <500 cells/µL)  
 Thrombocytopenia (platelets <50,000 cells/µL) 
Clinical Stage 4 
Conditions for which a presumptive diagnosis can be made on the basis of clinical signs or simple investigations 
 HIV wasting syndrome, (involuntary weight loss >10% of baseline body weight) 
associated with either chronic diarrhea (≥2 loose stools per day ≥1 month) or chronic 
weakness and documented fever ≥1 month  
 Pneumocystis jiroveci (formerly carinii) pneumonia  
 Recurrent severe or radiologic bacterial pneumonia  
 Chronic herpes simplex infection (oral or genital, or anorectal site) for >1 month  
 Esophageal candidiasis  
 Extrapulmonary tuberculosis  
 Kaposi sarcoma  
 Central nervous system toxoplasmosis  
 HIV encephalopathy 
Conditions for which a confirmatory diagnostic testing is necessary 
 Cryptococcosis, extra pulmonary  
 Disseminated nontuberculosis Mycobacteria infection  
 Progressive multifocal leukoencephalopathy  
 Candida of the trachea, bronchi, or lungs  
 Cryptosporidiosis  
 Isosporiasis  
 Visceral herpes simplex infection, cytomegalovirus infection (retinitis or organ other than 
liver, spleen, or lymph node)  
 Any disseminated mycosis (eg, histoplasmosis, coccidioidomycosis, penicilliosis)  
 Recurrent nontyphoidal Salmonella septicemia  
 Lymphoma (cerebral or B-cell non-Hodgkin)  
 Invasive cervical carcinoma  
 Visceral leishmaniasis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12.2 APPENDIX 2: GLOSSARY TO MASTER CHART 
 
 
 
Occupation 
1-unskilled labourer 
2-housewife 
3-skilled labourer 
4-police/army 
5-professional 
6-businessman 
7-unemployed 
 
Education 
1-none 
2-school 
3-graduate 
4-postgraduate 
 
Address 
1-TamilNadu 
2-AndhraPradesh 
3-Karnataka 
 
 
HIV status 
1-positive 
2-negative 
 
Any sexual partners outside marital relationship 
0-no 
1-yes 
 
Time since last sexual exposure outside marriage 
0-none 
1-< 6 months 
2-7-12 months 
3->12 months 
 
Blood transfusions, intravenous drug use, smoking 
0-no 
1-yes 
 
Alcohol 
0-none 
1-1-2 per week 
2-3-5 per week 
3-drinks daily 
 ART use 
0-no 
1-yes 
 
Condom use 
0-none 
1-occasionally 
2-always 
 
Other contraceptives 
0-none 
1-tubectomy 
2-oral contraceptive pills 
3-copper T 
 
Presence of genital ulcers or urethro-vaginal discharge 
0-no 
1-yes 
 
Diagnosis of previous or current STI 
0-none 
1-syphilis 
2-herpes 
3-candida 
4-viral warts 
 
VDRL status 
0-nonreactive 
1-reactive 
 
Male circumcision 
0-no 
1-yes 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
12.3 MASTER CHART OF DISCORDANT COUPLES IN THE STUDY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
            
 
 
 
 
 
 
 
 
 
 
 
12.4 MASTER CHART OF CONCORDANT COUPLES IN THE STUDY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
